Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells

Adoptive T cell therapy using chimeric antigen receptor (CAR)-modified T cells is a promising cancer immunotherapy. We previously developed a non-viral method of gene transfer into T cells using a piggyBac transposon system to improve the cost-effectiveness of CAR-T cell therapy. Here, we have furth...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Daisuke, Nishio, Nobuhiro, Saito, Shoji, Tanaka, Miyuki, Kawashima, Nozomu, Okuno, Yusuke, Suzuki, Satoshi, Matsuda, Kazuyuki, Maeda, Yasuhiro, Wilson, Matthew H., Dotti, Gianpietro, Rooney, Cliona M., Takahashi, Yoshiyuki, Nakazawa, Yozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907825/
https://www.ncbi.nlm.nih.gov/pubmed/29687032
http://dx.doi.org/10.1016/j.omtm.2017.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907825/
https://www.ncbi.nlm.nih.gov/pubmed/29687032
http://dx.doi.org/10.1016/j.omtm.2017.12.003

Ejemplares similares